Trial title not recorded
Atopic Dermatitis
Enrolment: 108 · Results not recorded
Drug · Glucocorticoid receptor agonist (AGONIST; direct interaction)
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Atopic Dermatitis
Enrolment: 108 · Results not recorded
Relapsing-remitting Multiple Sclerosis
Enrolment: 58 · Results not recorded
Breast Neoplasms · Mastectomy
Enrolment: 40 · Results not recorded
Chronic Graft-versus-host-disease
Enrolment: 240 · Results not recorded
Lupus Erythematosus, Systemic
Enrolment: 31 · Results not recorded
Dysphasia
Enrolment: 105 · Results not recorded
Bell's Palsy · Facial Nerve Paresis
Enrolment: 10 · Results not recorded
Allergic Bronchopulmonary Aspergilloses
Enrolment: 30 · Results not recorded
Graft Versus Host Disease
Enrolment: 52 · Results not recorded
Graft Versus Host Disease · Leukemia · Lymphoma
Enrolment not recorded · Results not recorded
CLL
Enrolment: 21 · Results not recorded
Acute Lymphoid Leukemia
Enrolment: 90 · Results not recorded
Diffuse Large B-Cell Lymphoma · Sintilimab · TP53 Mutation
Enrolment: 30 · Results not recorded
Multiple Sclerosis Relapsing Remitting · Treatment
Enrolment: 80 · Results not recorded
EBV-Positive DLBCL, Nos
Enrolment: 55 · Results not recorded
Rheumatoid Arthritis
Enrolment: 64 · Results not recorded
Prostate Cancer · Metastatic Cancer · Hormone Sensitive Prostate Cancer · Castration-resistant Prostate Cancer
Enrolment: 10 · Results not recorded
Sudden Deafness · Sensorineural Hearing Loss
Enrolment: 30 · Results not recorded
Myasthenia Gravis
Enrolment: 9 · Results not recorded
Diabetes · Healthy
Enrolment: 25 · Results not recorded
13 studies reported at therapy level; 13 evidence entries itemised.
Model: Acute experimental spinal cord injury (trauma model)
The nanoparticle-gel delivery system produced results very similar to systemic high-dose methylprednisolone sodium succinate on inflammatory cytokine levels and ultrastructural damage, which the authors interpret as supporting localised delivery at a lower administered dose. No superiority over the…
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
Model: Acute lung injury by single intratracheal bleomycin injection at 5 mg/kg for pathology, cytokine and lavage studies or 10 mg/kg for the survival study; controls received an equal volume of intratracheal saline
Lung-targeted methylprednisolone liposomes achieved higher lung drug accumulation, peak 30.8 versus 19.2 ug/g for untargeted, better histopathological improvement and lower inflammatory cytokines, and only the 1 mg/kg targeted group showed significantly higher 10-week survival, with no detectable l…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.
Model: Fluid percussion injury (traumatic brain injury)
High-dose methylprednisolone increased hypothalamic and pituitary apoptosis and exacerbated acute corticosteroid insufficiency and mortality after TBI.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.
Model: Thoracic irradiation, 24 Gy
Irradiation increased total lavage cells from 3 weeks, initially neutrophils then macrophages. At 6 weeks methylprednisolone-treated irradiated rats had significantly fewer total cells, macrophages, neutrophils and lymphocytes than saline-treated irradiated rats, indicating suppression of the acute…
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.
Model: Acute myocardial infarction
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.25. Machine-extracted fields require source verification.
Model: Smoke inhalation-induced acute lung injury (SI-ALI) with late-phase pulmonary fibrosis
A medium dose of 4 mg/kg markedly improved acute-phase survival compared with 0.4 mg/kg and 40 mg/kg, attenuated lung injury, and reduced proinflammatory cytokines and alveolar neutrophil infiltration. Medium and high doses improved coagulation and fibrinolysis relative to low dose. Three-day and 7…
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
Model: Acute spinal cord injury model
Methylprednisolone reduced spinal water content and aquaporin 4 expression relative to untreated injury, and improved histological appearance with clearer grey and white matter borders, reduced bleeding range, reduced karyopyknosis and less perivascular and neuronal oedema. The reported motor nerve…
Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.
Model: Clip compression of the spinal cord at a determined level
Spinal cord injury reduced Purkinje cell numbers and increased FNDC5 expression. Methylprednisolone inhibited apoptosis in FNDC5-immunoreactive Purkinje cells, restored these cells and reduced FNDC5 expression relative to untreated injury.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.62. Machine-extracted fields require source verification.
Model: Acute spinal cord injury in rats; the specific injury procedure is not stated in the abstract
Methylprednisolone improved the motor function score and reduced the expression and co-expression of aquaporin 4 and Kir4.1 relative to untreated injury, which the authors interpret as inhibition of medullospinal oedema.
Extraction: extract · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.
Model: Standardised lateral compression injury of the thoracic spinal cord under anaesthesia
Methylprednisolone 150 mg/kg in split doses reduced delayed loss of motor and sensory function without significantly lowering tissue quinolinic acid. A single 60 mg/kg dose at 5 h improved sensory function but the same dose at 10 h did not. A single dose of 4-chloro-3-hydroxyanthranilic acid at 5 h…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Compression spinal cord injury following laminectomy
Methylprednisolone improved Basso Mouse Scale recovery at 7 days, increased axonal survival at 72 hours, reduced histological damage and lowered microglial and macrophage proliferation compared with saline-treated injured mice.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.
Model: Surgically created full-thickness defect of the unilateral infraspinatus tendon, an acute rotator cuff tear
Subacromial methylprednisolone raised the type III to type I collagen ratio at 7 days and increased aggrecan and fibronectin at 3 days, suggesting early interference with healing, but these alterations normalised after the early inflammatory phase.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.
Model: Standardised experimental spinal cord injury
Mean ciliary neurotrophic factor expression was lower in the methylprednisolone group at 12 h (p = 0.006) and 24 h (p = 0.008) after injury than in the saline control group, with no significant difference at 6, 48 or 72 h. No functional outcome was reported.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.